Induction of apoptosis in toll-like receptor expressing...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/713 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2574176

Some types of cancer cells express one or more Toll-like receptors (TLRs). These TLRs are therapeutic targets. The invention relates to methods for treating Toll-like receptor expressing cancers and tumor cells by selecting a TLR expressing tumor cell and contacting the cell with a therapeutically effective amount of a TLR ligand. The invention particularly relates to methods for treating TLR3 expressing cancers and tumor cells using TLR3 agonists.

Certains types de cellules cancéreuses expriment un ou plusieurs récepteurs Toll-like (TLR). Ces TLR constituent des cibles thérapeutiques. L'invention concerne des méthodes de traitement de cancers et de cellules tumorales exprimant des récepteurs Toll-like, qui consistent à sélectionner une cellule tumorale exprimant TLR et à mettre celle-ci en contact avec une quantité thérapeutiquement efficace d'un ligand de TLR. L'invention concerne en particulier des procédés utilisant des agonistes de TLR3 pour traiter des cancers et des cellules tumorales exprimant des récepteurs TLR3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Induction of apoptosis in toll-like receptor expressing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Induction of apoptosis in toll-like receptor expressing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of apoptosis in toll-like receptor expressing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1961406

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.